[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"femur-head-necrosis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:femur-head-necrosis":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,46,80],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100226855","observational-study-to-evaluate-long-term-outcome-in-hip-arthroplasty-100226855",false,"NCT02230826","Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty","Multicentric Observational PMCF Study to Evaluate Long-term Outcome, Performance and Safety of Implantable Devices in Hip Arthroplasty","Inclusion Criteria:\n\n* Man or woman \\>18 years\n* Subjects with indication of arthroplasty surgery with Corin hip devices which are under assessment as part of this PMCF study\n* Subjects who agreed for study participation.\n\nExclusion Criteria:\n\n* Subjects with existing tumour and\u002For particularly high surgical risk-\n* Subjects with anaesthetic risk class IV or higher\n* Subjects under guardianship and\u002For unable to follow procedures or matters related to the study (examples: Illiterate, recent psychotic or mania disorders and \u002F or inability to comply with usual follow-up visits.)\n* Contraindications for arthroplasty with a Corin hip devices as per product IFU","ALL","18 Years",{"count":19,"type":20},2500,"ESTIMATED","OBSERVATIONAL","This long-term outcomes study is designed to collect safety and efficacy data on designated, commercially available, hip arthroplasty products.",[24,25,26,27,28],"Hip Replacement","Primary, Secondary or Post-traumatic Osteoarthrosis","Femur Head Necrosis","Congenital Dislocations","Primary and Revision Surgery",[30,24,31,32],"Arthroplasty","Acetabular cup","Femoral stem","RECRUITING","2026-03-17",{"date":36,"type":37},"2026-03-18","ACTUAL",{"date":39,"type":4},"2014-05",{"date":41,"type":20},"2044-12",{"name":43,"class":44},"Corin","INDUSTRY",13,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":54,"enrollmentInfo":55,"targetDuration":4,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":64,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":79},"100559575","phase-4-bupivacaine-liposome-plus-bupivacaine-or-ropivacaine-for-pericapsular-nerve-group-block-in-hip-arthroplasty-peng-100559575","NCT06565910","Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)","Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for PENG Block on Post Operative Pain Management in Patients Undergoing Hip Arthroplasty: a Prospective, Randomized, Single Blind, Active Controlled Study","PENG","Inclusion Criteria:\n\n* American Society of Anesthesiologists(ASA) I\\~II\n* Normal coagulation\n* Clinical diagnosis of hip fracture\n\nExclusion Criteria:\n\n* Presence of severe systemic diseases or ASA grade III or higher\n* Allergy to amide local anesthetics","60 Years",{"count":56,"type":20},60,"INTERVENTIONAL",[59],"PHASE4","The goal of this clinical trial is to study the analgesic effect of liposomal bupivacaine plus bupivacaine for Pericapsular Nerve Group (PENG) block in postoperative pain management following hip replacement surgery. It will also assess the safety of liposomal bupivacaine for this purpose. The main questions it aims to answer are:\n\n1. Is liposomal bupivacaine plus bupivacaine superior to ropivacaine in terms of analgesic efficacy, duration of pain relief, opioid consumption, and patient satisfaction?\n2. What medical problems do participants encounter when using liposomal bupivacaine plus bupivacaine for PENG block in postoperative pain management following hip replacement surgery?\n\nResearchers will compare liposomal bupivacaine plus bupivacaine to ropivacaine (a routinely used regional anesthetic in clinical practice) to determine if liposomal bupivacaine plus bupivacaine is more effective for pain management following hip replacement surgery.\n\nParticipants will:\n\n1. Receive liposomal bupivacaine plus bupivacaine or ropivacaine as a regional anesthetic for PENG block under ultrasound guidance.\n2. Undergo hip replacement surgery under spinal anesthesia.\n3. Have pain relief, opioid analgesic consumption, and incidence of complications assessed at multiple time points within 72 hours after surgery.",[62,26,63],"Femoral Neck Fractures","Hip Fractures",[65,66,67,68],"Bupivacaine Liposome","PENG block","Hip Arthroplasty","Randomized Controlled Trial","2026-03-11",{"date":71,"type":37},"2026-03-13",{"date":73,"type":37},"2024-12-04",{"date":75,"type":20},"2026-07-01",{"name":77,"class":78},"Huazhong University of Science and Technology","OTHER",1,{"id":81,"slug":82,"hasResults":11,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":86,"eligibilityCriteria":87,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":88,"enrollmentInfo":89,"targetDuration":91,"studyType":21,"phases":4,"briefSummary":92,"conditions":93,"keywords":4,"overallStatus":95,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":79},"100547600","difference-in-return-to-sports-activity-after-hip-arthroplasty-by-thr-or-resurfacing-100547600","NCT06410079","Difference in Return to Sports Activity After Hip Arthroplasty by THR or Resurfacing","Do Patients Under the Age of 50 Resume Equivalent Physical Activity Levels After Conventional Total Hip Replacement or Hip Resurfacing?","PTH-50","* Inclusion Criteria:\n* Participant is male or female, aged 50 or under\n* Participant is indicated for a primary THA or resurfacing procedure\n* Participant agrees to complete and receive questionnaires by email\n* Participant has been informed and has not objected to the collection and use of their data\n* Exclusion Criteria:\n* Participant is aged under 18 or over 50 years\n* Participant has had a previous THA or resurfacing procedure\n* Participant is scheduled for a THA on the other hip within the year\n* Participant has severe physical and\u002For psychological health problems that, in the investigators opinion, may affect the participant\\'s compliance with the study\n* Participant is participating in another research study\n* Participant is in the exclusion period of another research study that is still ongoing at the time of inclusion\n* Participant is a protected person: an adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision\n* Participant is pregnant, breastfeeding or giving birth\n* Participant is hospitalized without consent","50 Years",{"count":90,"type":20},500,"12 Months","This study aims to evaluate the return to activity in younger patients under 50 years old after undergoing either total hip replacement (THR) or hip resurfacing, as performed in everyday practice. This research will be observational, meaning patients will not be randomly assigned to different treatment groups. To objectively assess participents; return to everyday, professional, and sports activities, validated questionnaires will be sent to participents in addition to routine clinical practice. The study will be prospective and comparative based on the type of prostheses used.\n\nIn order to capture the current practices of surgeons performing THR in participents under 50 years old in France, the study will be conducted at multiple centers across the country. Since hip resurfacing is performed only in certain centers, approximately half of the participating centers are experienced in this technique.\n\nParticipents typically resume activity between 3 and 6 months after THR. One year of post-operative follow-up allows for an accurate assessment of participents; recovery, unaffected by the surgery. Participents ; physical activity levels will be evaluated using the UCLA Activity Scale developed by surgeons to assess the activity levels of patients undergoing hip and arthroplasty.",[94,26],"Hip Arthrosis","NOT_YET_RECRUITING","2024-05-08",{"date":98,"type":37},"2024-05-10",{"date":100,"type":20},"2024-06-01",{"date":102,"type":20},"2026-09-08",{"name":104,"class":78},"Société Française de chirurgie de la Hanche et du Genou"]